Invitation Homes, Inc. INVH 深 滬
已收盤 12-12 16:00:00 美东时间
26.35
-0.200
-0.75%
華盛通- 最 高26.71
- 今 開26.71
- 成交量 620.70万股
- 最 低 26.185
- 昨 收 26.55
- 總市值 161.53亿
- 52周最高 35.219
- 市盈率 靜 77.50
- 換手率 1.01%
- 52周最低 26.02
- 委 比 24.86%
- 總股本 6.13亿
- 歷史最高 41.60
- 量 比 1.16
- 振 幅 1.98%
- 歷史最低 10.31
- 每 手 1
- 風險率 1.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Invitation Homes Raises Quarterly Cash Dividend From $0.29 To $0.30 Per Share
Invitation Homes Inc. (NYSE:INVH) ("Invitation Homes," the "Company," or "our"), the nation's premier single-family home leasing and management company, announced today that it has declared a quarterly cash dividend of
12-13 05:16
Nasdaq 100 futures drop after another AI trade stumble
Stock index futures pointed to a mixed open Friday as AI momentum hit another speed bump. S&P 500 futures (SPX) slipped -0.11%, while Nasdaq futures (US100:IND) declined -0.47%. Dow futures (INDU) buc...
12-12 18:47
Invitation Homes Highlights Strategy in December 2025 Meeting
Invitation Homes ( ($INVH) ) just unveiled an update. In a presentation for upc...
12-08 20:20
Alexandria Real Estate dividend cut spooks investors, but these other REITs are likely safe
Alexandria Real Estate Equities (ARE) stock was the second-biggest percentage decliner on the S&P 500 this week, after the real estate investment trust (REIT) on Wednesday nearly halved its quarterly ...
12-07 02:57
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
11-26 10:07
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
JP Morgan Maintains Overweight on Invitation Homes, Lowers Price Target to $37
JP Morgan analyst Anthony Paolone maintains Invitation Homes (NYSE:INVH) with a Overweight and lowers the price target from $38 to $37.
11-18 23:52
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
